Up to 40% of allergic rhinitis (AR) patients have comorbid asthma with need for treatment. Poor control of AR predicts poor control of asthma and may necessitate increased use of rescue treatment. We evaluated the effect of MP-AzeFlu on asthma symptoms and reliever medication use in patients with comorbid AR and asthma.
|Number of pages||1|
|Journal||Journal of Allergy and Clinical Immunology|
|Issue number||2, Supplement|
|Early online date||24 Feb 2020|
|Publication status||Published - Feb 2020|
|Event||2020 AAAAI Annual Meeting - Philadelphia, United States|
Duration: 13 Mar 2020 → 16 Mar 2020